Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: Salicylate, indomethacin, oxyphenbutazone, sulindac
- 1 July 1982
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 35 (1) , 21-27
- https://doi.org/10.1016/s0014-4835(82)80019-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- ACETYLSALICYLIC ACID IN DIABETESThe Lancet, 1981
- ASPIRIN AND SENILE CATARACTS IN RHEUMATOID ARTHRITISThe Lancet, 1981
- Glucose tolerance tests in 200 patients with senile cataract.British Journal of Ophthalmology, 1980
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979
- Pharmacokinetics of Salicylates in ElderlyGerontology, 1979
- Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.British Journal of Ophthalmology, 1973
- Salicylate and enzymesJournal of Pharmacy and Pharmacology, 1971
- Effects of acetylsalicylic acid on serum protein binding and metabolism of tryptophan in manJournal of Pharmacy and Pharmacology, 1971
- Polyol Pathway in Aorta: Regulation by HormonesScience, 1969
- Cataract and DiabetesBMJ, 1964